ADT1470-Opicinumab Biosimilar-(LINGO1/LRRN6A/LERN1)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1470 |
Product Name |
ADT1470-Opicinumab Biosimilar-(LINGO1/LRRN6A/LERN1)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse LINGO1 antibody, anti-LINGO1 antibody, anti LINGO1 antibody, recombinant LINGO1, LINGO1 antibody, anti-LINGO1 monoclonal antibody, LINGO1 antibodies, LINGO1 recombinant antibody, LINGO1 blocking antibody, LRRN6A recombinant antibody, LRRN6A blocking antibody, LERN1 recombinant antibody, LERN1 blocking antibody, |
|
Alias |
BIIB-033 |
Host |
CHO Cells |
Species |
Human |
Target |
LINGO1/LRRN6A/LERN1 |
Isotype |
IgG1 Kappa |
Size |
1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1422268-07-2 |
Product Description |
Opicinumab (BIIB033) is a fully human monoclonal antibody designed for the treatment of multiple sclerosis, acute optic neuritis (AON), and other associated demyelinating diseases. A biologic drug, it is designed to function as a LINGO-1 protein antagonist, known as “Anti-Lingo-1”. |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |





